- Home
- CRS vs NBIX Comparison
CRS vs NBIX Comparison
Compare CRS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRS
- NBIX
- Stock Information
- Founded
- CRS 1910
- NBIX 1992
- Country
- CRS United States
- NBIX United States
- Employees
- CRS N/A
- NBIX N/A
- Industry
- CRS Steel/Iron Ore
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRS Industrials
- NBIX Health Care
- Exchange
- CRS Nasdaq
- NBIX Nasdaq
- Market Cap
- CRS 15.4B
- NBIX 14.4B
- IPO Year
- CRS N/A
- NBIX 1996
- Fundamental
- Price
- CRS $321.36
- NBIX $142.88
- Analyst Decision
- CRS Strong Buy
- NBIX Strong Buy
- Analyst Count
- CRS 5
- NBIX 18
- Target Price
- CRS $374.60
- NBIX $172.33
- AVG Volume (30 Days)
- CRS 731.3K
- NBIX 1.2M
- Earning Date
- CRS 10-23-2025
- NBIX 10-28-2025
- Dividend Yield
- CRS 0.25%
- NBIX N/A
- EPS Growth
- CRS 82.03
- NBIX 12.44
- EPS
- CRS 8.18
- NBIX 4.19
- Revenue
- CRS $2,893,200,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- CRS $8.82
- NBIX $23.68
- Revenue Next Year
- CRS $9.90
- NBIX $18.02
- P/E Ratio
- CRS $39.27
- NBIX $34.24
- Revenue Growth
- CRS 2.40
- NBIX 19.61
- 52 Week Low
- CRS $138.61
- NBIX $84.23
- 52 Week High
- CRS $342.11
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- CRS 58.20
- NBIX 49.67
- Support Level
- CRS $295.00
- NBIX $139.27
- Resistance Level
- CRS $332.07
- NBIX $144.83
- Average True Range (ATR)
- CRS 14.42
- NBIX 4.41
- MACD
- CRS -3.59
- NBIX -0.77
- Stochastic Oscillator
- CRS 55.89
- NBIX 30.77
About CRS Carpenter Technology Corporation
Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.